Close

Immunovant, Inc. (IMVT) Misses Q3 EPS by 10c

February 3, 2023 7:03 AM EST

Immunovant, Inc. (NASDAQ: IMVT) reported Q3 EPS of ($0.49), $0.10 worse than the analyst estimate of ($0.39).


For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings